2024 – Study C601/C602-Open Label Extension
Miller JL, Gevers E, Bridges N, et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study. Obesity (Silver Spring). 2024;32(2):252-261.
You are now leaving Soleno Medical
The link you are selecting will direct you to an external website maintained by third parties that are neither owned, endorsed, nor controlled by Soleno. The link is provided for your convenience and informational purposes only.
Soleno does not endorse or control the content, privacy policies, or terms of use/services on external sites. Any opinions, claims, or comments expressed on external sites should not be attributed to Soleno.
